期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 380, 期 15, 页码 1476-1478出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMe1903193
关键词
-
Some trials fail because the experimental treatment proves to be no different than a control or standard intervention. Others fail because of unacceptable side effects. In this issue of the Journal, an article by Egan et al.(1) and a letter to the editor by Henley et al.(2) describe a third reason for failure - a treatment worsens the target symptoms. The therapeutic intervention of lowering brain amyloid-beta (A beta) peptide levels to treat patients with Alzheimer's disease is based on a conceptual model in which accumulation of A beta is causally related to cognitive decline. The model is rooted in the inseparability . . .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据